Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eiber

Showing results (231-240 of 377) with videos related to

Pageof 38
Sort By:
International Journal of Computer Assisted Radiology and Surgery|June 10, 2015
Multimodal image-guided prostate fusion biopsy based on automatic deformable registrationOliver Zettinig, Amit Shah, Christoph Hennersperger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteriaAndrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2013
Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesionsMatthias Eiber, Toshiki Takei, Michael Souvatzoglou, et al.
JMIR Research Protocols|April 29, 2026
Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational StudyKerstin Michalski, Theo Lorenzini, Tim Jedamzik, et al.
Journal of Hematology & Oncology|March 7, 2014
Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancerMark Thalgott, Thomas Horn, Matthias M Heck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center StudyIda Sonni, Matthias Eiber, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2019
Histologically Confirmed Diagnostic Efficacy of <sup>18</sup>F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate CancerMarkus Kroenke, Alexander Wurzer, Kristina Schwamborn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2019
Can the Injected Dose Be Reduced in <sup>68</sup>Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?Isabel Rauscher, Wolfgang P Fendler, Thomas A Hope, et al.
European Urology|May 11, 2015
Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancerTobias Maurer, Gregor Weirich, Margret Schottelius, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 21, 2011
Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesionsMatthias Eiber, Axel Martinez-Möller, Michael Souvatzoglou, et al.
Pageof 38

Showing results (231-240 of 377) with videos related to

Sort By:
Pageof 38
International Journal of Computer Assisted Radiology and Surgery|June 10, 2015
Multimodal image-guided prostate fusion biopsy based on automatic deformable registrationOliver Zettinig, Amit Shah, Christoph Hennersperger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 29, 2022
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteriaAndrei Gafita, Isabel Rauscher, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2013
Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesionsMatthias Eiber, Toshiki Takei, Michael Souvatzoglou, et al.
JMIR Research Protocols|April 29, 2026
Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational StudyKerstin Michalski, Theo Lorenzini, Tim Jedamzik, et al.
Journal of Hematology & Oncology|March 7, 2014
Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancerMark Thalgott, Thomas Horn, Matthias M Heck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2020
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center StudyIda Sonni, Matthias Eiber, Wolfgang P Fendler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2019
Histologically Confirmed Diagnostic Efficacy of <sup>18</sup>F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate CancerMarkus Kroenke, Alexander Wurzer, Kristina Schwamborn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2019
Can the Injected Dose Be Reduced in <sup>68</sup>Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?Isabel Rauscher, Wolfgang P Fendler, Thomas A Hope, et al.
European Urology|May 11, 2015
Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancerTobias Maurer, Gregor Weirich, Margret Schottelius, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 21, 2011
Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesionsMatthias Eiber, Axel Martinez-Möller, Michael Souvatzoglou, et al.
Pageof 38